The Valens Company Inc.
$0.76+0.00%(+$0.00)
TickerSpark Score
61/100
100
Valuation
40
Profitability
72
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VLNS research report →
52-Week Range7% of range
Low $0.58
Current $0.76
High $3.00
Companywww.thevalenscompany.com
The Valens Company Inc. develops, manufactures, and sells cannabinoid-based products in Canada and internationally. It produces dried cannabis and hemp biomass products.
- CEO
- Jeffrey Fallows CFA
- IPO
- 2009
- Employees
- 445
- HQ
- Toronto, ON, CA
Price Chart
-66.21% · this period
Valuation
- Market Cap
- $61.46M
- P/E
- -0.88
- P/S
- 0.00
- P/B
- 0.17
- EV/EBITDA
- 0.02
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 22.05%
- Op Margin
- -69.06%
- Net Margin
- -62.72%
- ROE
- -25.35%
- ROIC
- -16.24%
Performance & Tape
- 52W High
- $3.00
- 52W Low
- $0.58
- 50D MA
- $0.78
- 200D MA
- $0.79
- Beta
- 0.00
- Avg Volume
- 120.95K
Get TickerSpark's AI analysis on VLNS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our VLNS Coverage
We haven't published any research on VLNS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate VLNS Report →Similar Companies
DRRX-1.04%
DURECT Corporation
$1.91
RPHM+952.02%
Reneo Pharmaceuticals, Inc.
$18.20
ZYNE+2.36%
Zynerba Pharmaceuticals, Inc.
$1.30
ACHL+0.68%
Achilles Therapeutics plc
$1.48
NEUE+0.00%
NeueHealth, Inc.
$6.75
LIEN+0.20%
Chicago Atlantic BDC, Inc.
$9.81
AKYA-5.15%
Akoya Biosciences, Inc.
$1.29
HTBX+0.42%
Heat Biologics, Inc.
$2.38